Gordon Ng
Plus aucun poste en cours
Profil
Gordon Ng worked as a Scientific Director at Amgen, Inc. from 2002 to 2011.
He then worked as a Director at Myelin Repair Foundation, Inc. After that, he worked as a Vice President-Preclinical Research & Development at Zymeworks BC, Inc. from 2012 to 2014.
Prior to that, he worked as a Principal at Merck Frosst Canada Ltd.
Dr. Ng received his undergraduate degree from the University of British Columbia and his graduate and doctorate degrees from the University of Toronto.
Anciens postes connus de Gordon Ng
Sociétés | Poste | Fin |
---|---|---|
AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/01/2011 |
Merck Frosst Canada Ltd.
Merck Frosst Canada Ltd. Pharmaceuticals: MajorHealth Technology Merck Frosst Canada Ltd. is a Canadian pharmaceutical company that has been inventing medicines and vaccines for over 130 years. The company is based in Kirkland, Canada. The company's mission is to save and improve lives by bringing forward solutions for some of the world's most challenging diseases. | Corporate Officer/Principal | - |
Myelin Repair Foundation, Inc.
Myelin Repair Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Myelin Repair Foundation, Inc. is a non-profit organization that operates to provide funds for research that lead to publications of scientific articles. It offers discovery biology, translational medicine, and clinical researches. The company was founded by Scott Johnson in 2004 and is headquartered in Saratoga, CA. | Directeur/Membre du Conseil | - |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Directeur Technique/Scientifique/R&D | - |
Formation de Gordon Ng
University of Toronto | Doctorate Degree |
University of British Columbia | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
AMGEN INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
Myelin Repair Foundation, Inc.
Myelin Repair Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Myelin Repair Foundation, Inc. is a non-profit organization that operates to provide funds for research that lead to publications of scientific articles. It offers discovery biology, translational medicine, and clinical researches. The company was founded by Scott Johnson in 2004 and is headquartered in Saratoga, CA. | Commercial Services |
Merck Frosst Canada Ltd.
Merck Frosst Canada Ltd. Pharmaceuticals: MajorHealth Technology Merck Frosst Canada Ltd. is a Canadian pharmaceutical company that has been inventing medicines and vaccines for over 130 years. The company is based in Kirkland, Canada. The company's mission is to save and improve lives by bringing forward solutions for some of the world's most challenging diseases. | Health Technology |